Brazilian chemical industries face several problems regarding Research, Development and Innovation (RDI). The present paper shows that simple cooperation between chemical industries and university laboratories can be a way to overcome some of the present difficulties. The work carried out at LABOCAT has several industrial interfaces. It involves, among other areas of RDI, the development of anti-HIV-protease (and other virus-related-protease) drugs, the establishment of new (industrial) chemical processes and the implementation of industrial (biodiesel and related) plants. A model based on the present so called RHAE programme is proposed in which, parallel to the fellowship awards of this programme, financing participation of Brazilian Agencies would cover process development.
process development; pharmaceuticals; biotechnology
